Anthracycline-induced cardiomyopathy: secrets and lies

Dimitrios Farmakis¹, Marina Mantzourani², Gerasimos Filippatos^{1

3}

Affiliations

¹ Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
² First Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
³ Universtiy of Cyprus Medical School, Nicosia, Cyprus.

Free article

Editorial

Dimitrios Farmakis et al. Eur J Heart Fail. 2018 May.

Free article

. 2018 May;20(5):907-909.

doi: 10.1002/ejhf.1172. Epub 2018 Mar 1.

Dimitrios Farmakis¹, Marina Mantzourani², Gerasimos Filippatos^{1

3}

¹ Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
² First Department of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
³ Universtiy of Cyprus Medical School, Nicosia, Cyprus.

No abstract available

Comment on

Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.
Fornaro A, Olivotto I, Rigacci L, Ciaccheri M, Tomberli B, Ferrantini C, Coppini R, Girolami F, Mazzarotto F, Chiostri M, Milli M, Marchionni N, Castelli G. Fornaro A, et al. Eur J Heart Fail. 2018 May;20(5):898-906. doi: 10.1002/ejhf.1049. Epub 2017 Nov 16. Eur J Heart Fail. 2018. PMID: 29148208